Clinical implications of benign multiple sclerosis: A 20-year population-based follow-up study

Sean J. Pittock, Robyn L. McClelland, William T. Mayr, Neal W. Jorgensen, Brian G. Weinshenker, John Noseworthy, Moses Rodriguez

Research output: Contribution to journalArticlepeer-review

176 Scopus citations

Abstract

In 2001, we followed up all patients from the 1991 Olmsted County Multiple Sclerosis (MS) prevalence cohort. We found that the longer the duration of MS and the lower the disability, the more likely a patient is to remain stable and not progress. This is particularly powerful for patients with benign MS with Expanded Disability Status Scale score of 2 or lower for 10 years or longer who have a greater than 90% chance of remaining stable. This is important because these patients represent 17% of the entire prevalence cohort. These data should assist in the shared therapeutic decision-making process of whether to start immunomodulatory medications.

Original languageEnglish (US)
Pages (from-to)303-306
Number of pages4
JournalAnnals of neurology
Volume56
Issue number2
DOIs
StatePublished - Aug 2004

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Clinical implications of benign multiple sclerosis: A 20-year population-based follow-up study'. Together they form a unique fingerprint.

Cite this